Multicenter study to assess surgical treatments of 452 sinonasal intestinal-type adenocarcinomas: A REFCOR study.


Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
01 2023
Historique:
received: 22 04 2022
revised: 11 07 2022
accepted: 24 07 2022
pubmed: 23 8 2022
medline: 24 1 2023
entrez: 22 8 2022
Statut: ppublish

Résumé

The objective was to assess the local oncological outcomes of endoscopic versus external surgical treatment of sinonasal intestinal-type adenocarcinomas (ITAC) and the factors of recurrence. a retrospective non-randomized case-control multicenter study was carried out, including 452 untreated sinonasal ITACs recruited from 10 tertiary referral centers. The tumors were re-classified according to the UICC 2017 (pT). Survival curves were obtained using the Kaplan-Meier method. Univariate analysis was done with the log-rank test. Multivariate analysis was performed with a Cox model adjusted for age, T stage, and radiotherapy. A binary logistic regression compared surgical complications and performed two supplementary analyses on positive margins. We compared 195 and 257 patients operated by the external and endoscopic approach, respectively. The mean follow-up was 59.2 ± 48.7 months. Post-operative margins were invaded in 30.6 versus 18.9% of patients, respectively (p = 0.007). The overall recurrence rate was 33.8 versus 24.6%, respectively (p = 0.034). There was a significant difference in favor of the endoscopic approach regarding local recurrence-free survival thanks to better surgical margins in univariate and multivariate analysis (Odd Ratio = 2.01 (1.2-3.36) p = 0.0087). The complication rate (Odds Ratio = 3.4 (1.79-6.32) p < 0.001) was significantly lower in the endoscopic group. The histological positivity of signet-ring cells shows a statistically significant difference in recurrence-free survival (p = 0.0028). the oncological control of ITAC is better through the endoscopic approach, with negative margins and the absence of signet-ring-cells, two independent factors of recurrence.

Identifiants

pubmed: 35995650
pii: S0748-7983(22)00582-0
doi: 10.1016/j.ejso.2022.07.021
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-46

Informations de copyright

Copyright © 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ludovic de Gabory (L)

Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Bordeaux, Bordeaux, France; Univ. Bordeaux, 33000, France. Electronic address: ludovic.de-gabory@chu-bordeaux.fr.

Alice Waubant (A)

Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Bordeaux, Bordeaux, France.

Benjamin Verillaud (B)

Department of Otorhinolaryngology - Head and Neck Surgery, Lariboisière University Hospital, Paris, France.

Justin Michel (J)

Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Marseille, AP-HM Marseille, France.

Olivier Malard (O)

Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Nantes, Nantes, France.

Cécile Rumeau (C)

Departement of Otorhinolaryngology, Université de Lorraine, CHRU Nancy, Service ORL, F-54000, Nancy, France.

Roger Jankowski (R)

Departement of Otorhinolaryngology, Université de Lorraine, CHRU Nancy, Service ORL, F-54000, Nancy, France.

Antoine Moya-Plana (A)

Department of Otorhinolaryngology - Head and Neck Surgery, Gustave Roussy Cancer Center, Villejuif, France.

Sebastien Vergez (S)

Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Toulouse, Toulouse, France.

Valentin Favier (V)

Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Montpellier, Montpellier, France.

Geoffrey Mortuaire (G)

Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Lille, Lille, France.

Christian Righini (C)

Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Grenoble, Grenoble, France.

Vincent Patron (V)

Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Caen, Caen, France.

Juliette Thariat (J)

Centre Francois Baclesse, Cancer Research Center, Department of Oncology, 3, Avenue du Général Harris, 14000, Caen, France.

Charles Dupin (C)

Departement of Oncology and Radiotherapy, Hôpital Haut-Lévêque, University Hospital of Bordeaux, Avenue Magellan, 33600, Pessac, France.

Julien Coelho (J)

Pôle de Santé Publique, Clinical Epidemiology Unit (USMR), F-33000, Bordeaux, France.

Antoine Bénard (A)

Pôle de Santé Publique, Clinical Epidemiology Unit (USMR), F-33000, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH